MacroGenics | MGNX - Kapitał Akcyjny





Kapitał Akcyjny Zmiana Data
AbbVie USD 1.77B 1.75B 2025-06
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Daiichi Sankyo JPY 1.85B 9K 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Genmab DKK 61.62M 52K 2025-12
Geron USD 640.9M 2.54M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
J&J USD 2.41B 1.74M 2025-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
MacroGenics USD 63.32M 60K 2025-12
Merck USD 2.47B 12.72M 2025-12
Pfizer USD 5.7B 13M 2026-03
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Xencor USD 74.06M 2.19M 2026-03